A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903

Clinical trial NCT06846099 · COMPLETED

Trial details

NCT number: NCT06846099
Sponsor: Risen (Suzhou) Pharma Tech Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Cervical Cancer Endometrial Cancer Breast Cancer Solid Tumor Cancer

Start date: 2022-12-07
Primary completion: 2025-05-30
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.